The biological properties of cancer stem cells in malignant gliomas in tissue culture: a review

Home/2015, Vol. 3, No. 2/The biological properties of cancer stem cells in malignant gliomas in tissue culture: a review

Cell and Organ Transplantology. 2015; 3(2):163-168.
DOI: 10.22494/COT.V3I2.12

The biological properties of cancer stem cells in malignant gliomas in tissue culture: a review

Semenova V. M., Lisyany N. I., Rosumenko V. D., Egorova D. M., Staino L. P.
A. P. Romodanov State Institute of Neurosurgery NAMS of Ukraine, Kyiv, Ukraine

Abstract
This review presents recent data on the biological properties of cancer stem cells in brain gliomas. The possibilities of using of experimental methods of cell culture and immunohistochemical identification of tumor stem cells as a part of neurospheres (tumorospheres) are shown. Methodological features of neurospheres culture are described.
Literature data about the dependence of neurospheres formation activity in the culture on the degree of anaplasia of original glioma tissues are presented considering the disease outcomes in neuro-oncological patients. Possibilities of the practical use of cultured tumorospheres in the study of selective impact of antiblastic drugs on tumor stem cells in gliomas are described.

Key words: cancer stem cells, glioma, cell culture, neurosphere

Full Text PDF

1. Gursel DB, Shin BJ, Burkhardt J-K, et. al. Glioblastoma Stem-Like Cells – Biology and Therapeutic Implications. Cancers. 2011; 3(2):2655–2666.
https://doi.org/10.3390/cancers3022655
PMid:21796273 PMCid:PMC3142771
2. Park DM. Biology of Glioma Cancer Stem Cells. Mol. Cells. 2009; 28:7–12.
https://doi.org/10.1007/s10059-009-0111-2
PMid:19655094
3. Lisyany NI. Immunologija i immunoterapija zlokachestvennyh gliom golovnogo mozga. [Immunology and Immunotherapy of malignant gliomas of the brain]. Serija “Nejroimmunologija” Kiev: Interservis – Series “Neuroimmunology”. Kiev: Interservice. 2011; 5:240 p.
4. Wang JC. Evaluating Therapeutic efficacy against cancer stem cells: New challenges posed by a new paradigm. Cell Stem Cell. 2007; 1:497–501.
https://doi.org/10.1016/j.stem.2007.10.005
PMid:18938746
5. Bleau AM, Howard BM, Taylor LA, et al. New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans Neurosurg. Focus. 2008; 24(3-4):E 28.
6. Pollard SM, Yoshikawa K, Clarke ID, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 2009; 4:568–580.
https://doi.org/10.1016/j.stem.2009.03.014
PMid:19497285
7. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. Engl. J. Med. 2005; 353:811–822.
https://doi.org/10.1056/NEJMra043666
PMid:16120861
8. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006; 9:391–403.
https://doi.org/10.1016/j.ccr.2006.03.030
PMid:16697959
9. Kong BH, Park N-R, Shim J-K, et al. Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens. Child’s Nervous System. 2013; 29(2):217–229.
https://doi.org/10.1007/s00381-012-1964-9
PMid:23143002
10. Kok M, Koornstra RH, Margarido TC, et al. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer. The Journal of Pathology. 2009; 218(3):316–326.
https://doi.org/10.1002/path.2544
PMid:19353633
11. Kim HS, Yoo SY, Kim KT, et al. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance. International Journal of Clinical and Experimental Pathology. 2012; 5(8):754–761.
PMid:23071857 PMCid:PMC3466976
12. Pirozzi G, Tirino V, Camerlingo R, et al. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Oncology Reports. 2013; 29(5):1763–1768.
https://doi.org/10.3892/or.2013.2294
13. Bao B, Ali S, Ahmad A, et al. Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer. Stem Cells and Development. 2014; 23(16):1947–1958.
https://doi.org/10.1089/scd.2013.0551
PMid:24734907
14. Wang X, Ren H, Zhao T, et al. Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection. Carcinogenesis. 2014; 35(10):2283–2290.
https://doi.org/10.1093/carcin/bgu162
PMid:25086759
15. Reya T, Morrison SJ, Clarce MF, et al. Stem cells cancer and cancer stem cells. Nature. 2001; 414:105–111.
https://doi.org/10.1038/35102167
PMid:11689955
16. Singh SK, Clarke ID, Terasaki M, et al. Identification of Cancer Stem Cell in Human Brain Tumors. Cancer Res. 2003; 63(18):5821–5828.
PMid:14522905
17. Sulman E. Aldape K, Colman H. Brain tumor stem cells. Current Problems in Cancer. 2008; 32(3):124–142.
https://doi.org/10.1016/j.currproblcancer.2008.02.004
PMid:18501775
18. Binello E, Qadeer ZA, Kothari HP, Emdad L, et al. Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In Vitro. J. Cancer. 2012; 3:166–174.
https://doi.org/10.7150/jca.4149
PMid:22514559 PMCid:PMC3328782
19. Dahlstrand J, Collins VP, Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer res. 1992; 52:5334–5341.
PMid:1382841
20. Tohyama T, Lee VM, Rorke LB, et al. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab. Invest. 1992; 66:303–313.
PMid:1538585
21. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumor initiating cells. Nature. 2004; 432:396–401.
https://doi.org/10.1038/nature03128
PMid:15549107
22. Ben-Porath I, Thomson NW, Carev V J, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008; 40:499–507.
https://doi.org/10.1038/ng.127
PMid:18443585 PMCid:PMC2912221
23. Mishima K, Kato Y, Kaneko MK, et al. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathologica. 2006; 111(5):483–488.
https://doi.org/10.1007/s00401-006-0063-y
PMid:16596424
24. Laks DR, Masterman-Smith M, Visnyei K, et al. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells. 2009; 27(4):980–987.
https://doi.org/10.1002/stem.15
PMid:19353526 PMCid:PMC3177534
25. Dahlrot RH, Hermansen SK, Hansen S, et al. What is the clinical value of cancer stem cell markers in gliomas? International Journal of Clinical and Experimental Pathology. 2013; 6(3):334–348.
PMid:23412423 PMCid:PMC3563206
26. Christensen K, Schrøder HD, Kristensen BW. CD133 identifies perivascular niches in grade II-IV astrocytomas. Journal of Neuro-Oncology. 2008; 90(2):157–170.
https://doi.org/10.1007/s11060-008-9648-8
PMid:18612800
27. Kim K-J, Lee K-H, Kim H-S, et al. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology. 2011; 31(5):494–502.
https://doi.org/10.1111/j.1440-1789.2010.01194.x
PMid:21269333
28. Schoppmann SF, Berghoff AS, Jesch B, et al. Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis. Future Oncology. 2012; 8(7):859–866.
https://doi.org/10.2217/fon.12.71
PMid:22830405
29. Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 1992; 12:4565–4574.
PMid:1432110
30. Singec I, Knoth R, Meyer RP, et al. Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat. Methods. 2006; 3:801–806.
https://doi.org/10.1038/nmeth926
PMid:16990812
31. Hasselbach LA, Irtenkauf SM, Lemke NW, et al. Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry. J. Vis. Exp. 2014; 83(e51088):1–9.
https://doi.org/10.3791/51088
32. Qiang L, Yang Y, Ma YJ, et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett. 2009; 279(1):13–21.
https://doi.org/10.1016/j.canlet.2009.01.016
PMid:19232461
33. Gilbert CA, Ross AH. Cancer Stem cells: Cell Culture, Markers and Targets for New Therapies. J.Cell.Biochem. 2009; 108(5):1031–1038.
https://doi.org/10.1002/jcb.22350
PMid:19760641 PMCid:PMC2909872
34. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad .Sci. USA. 2003; 100:15178–15183.
https://doi.org/10.1073/pnas.2036535100
PMid:14645703 PMCid:PMC299944
35. Ahmed S. The culture of neural stem cells. J. Cell Biochem. 2009; 106:1–6.
https://doi.org/10.1002/jcb.21972
PMid:19021147
36. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004; 64(19):7011–7021.
https://doi.org/10.1158/0008-5472.CAN-04-1364
PMid:15466194
37. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat. Rev. Cancer. 2006; 6:425–436.
https://doi.org/10.1038/nrc1889
PMid:16723989
38. deCarvalho AC, Nelson K, Lemke N, et al. Gliosarcoma Stem Cells Undergo Glial and Mesenchymal Differentiation In Vivo. Stem Cells. 2010; 28(2):181–190.
PMid:19937755 PMCid:PMC2873790
39. Azari H, Millette S, Ansari S, et al. Isolation and expansion of human glioblastoma multiforme tumor cells using the neurosphere assay. J. Vis. Exp. 2011; 56(e3633):1–5.
https://doi.org/10.3791/3633
40. Woolard K, Fine HA. Glioma stem cells: better flat than round. Cell Stem Cell. 2009; 4: 466–467.
https://doi.org/10.1016/j.stem.2009.05.013
PMid:19497271
41. Facchino S, Abdouh M, Chatoo W, et al. BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J.Neurosci. 2010; 28(30):1096–1111.
https://doi.org/10.1523/jneurosci.1634-10.2010
42. Yi L, Zhou C, Wang B, et al. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngenic graft model for research on glioma-initiating cells. Int.J.Oncol. 2013; 43(2): 477–484.
PMid:23708048
43. Pavon LF, Marti LC, Sibov TT, et al. In vitro analysis of neurospheres derived from glioblastoma primary culture: a novel methodology paradigm. Front.Neurol. 2014; 4:214–220.
https://doi.org/10.3389/fneur.2013.00214
PMid:24432012 PMCid:PMC3883037
44. Li SC, Long TV, Ho HW, et al. Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall. Cancer Cell International. 2012; 12:41–60.
https://doi.org/10.1186/1475-2867-12-41
PMid:22995409 PMCid:PMC3546918
45. Bao S, Wu Q, MCLendon DE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006a; 444:756–760.
https://doi.org/10.1038/nature05236
PMid:17051156
46. Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD1339(-) glioblastoma-derived cancer stem cell show differential growth characteristics and molecular profiles. Cancer Res. 2007; 67: 4010–4015.
https://doi.org/10.1158/0008-5472.CAN-06-4180
PMid:17483311
47. Joo KM, Kim SY, Jin X, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab. Invest. 2008; 88:808–815.
https://doi.org/10.1038/labinvest.2008.57
PMid:18560366
48. Son MJ, Woolard K, Nam DH, et al. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem cell. 2009; 4:440–452.
https://doi.org/10.1016/j.stem.2009.03.003
PMid:19427293
49. Clement V, Marino D, Cudalbu C, et al. Marker-independent identification of glioma-initiating cells. Nature Methods. 2010; 7:224–228.
https://doi.org/10.1038/nmeth.1430
PMid:20173750
50. Ignatova TN, Kukekov VG, Laywell ED, et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia. 2002; 39(3):193–206.
https://doi.org/10.1002/glia.10094
PMid:12203386
51. Yuan X, Curtin J, Xion Y, et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 2004; 23:9392–9400.
https://doi.org/10.1038/sj.onc.1208311
PMid:15558011
52. Germano IM, Swiss V, Casaccia P. Primary brain tumors, neural stem cells, and brain tumor cancer cells: Where is the link? Neuropharmacol. 2010; 58(6):903–910.
https://doi.org/10.1016/j.neuropharm.2009.12.019
PMid:20045420 PMCid:PMC2839061
53. Strojnik T, Røsland GV, Sakariassen PO, et al. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surgical Neurology. 2007; 68(2):133–143.
https://doi.org/10.1016/j.surneu.2006.10.050
PMid:17537489
54. Beier D, Rohrl S, Pillai DR, et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res. 2008; 68:5706–5715.
https://doi.org/10.1158/0008-5472.CAN-07-6878
PMid:18632623
55. Pallini R, Ricci-Vitiani L, Banna GL, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clinical Cancer Research. 2008; 14(24):8205–8212.
https://doi.org/10.1158/1078-0432.CCR-08-0644
PMid:19088037
56. Zeppernick F, Ahmadi R, Campos B, et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res. 2008; 14(1):123–129.
https://doi.org/10.1158/1078-0432.CCR-07-0932
PMid:18172261
57. Zhang M, Song T, Yang L, et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res. 2008; 27: 85–92.
https://doi.org/10.1186/1756-9966-27-85
PMid:19108713 PMCid:PMC2633002
58. Wang X, Ren H, Zhao T, et al. Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection. Carcinogenesis. 2014; 35(10):2283–2290.
https://doi.org/10.1093/carcin/bgu162
PMid:25086759
59. Kong BH, Moon JH, Huh UM, et al. Prognostic Value of Glioma Cancer Stem Cell Isolation in Survival of Primary Glioblastoma Patients. Stem Cells International. 2014; Article ID 838950. 6 p.
60. S. Bao, Q. Wu, Z. Li, S. Sathornsumetee, H. Wang, R.E. McLendon, A.B. Hjelmeland, J.N. Rich Targeting cancer stem cells through L1CAM suppresses glioma grouth / // Cancer Res. – 2008. – Vol. 68. – P. 7043–6048.
61. Dietrich J, Imitola J, Kesari S. Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas . Nat.Clin.Pract. 2008; 5:393–404.
https://doi.org/10.1038/ncponc1132
PMid:18521117
62. Bao S, Wu Q, Sathornsumetae S, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer.Res. 2006b; 66:7843–7848.
https://doi.org/10.1158/0008-5472.CAN-06-1010
PMid:16912155
63. Ernst A, Hofmann S, Ahmadi R, et al. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clinical Cancer Research. 2009; 15(21):6541–6550.
https://doi.org/10.1158/1078-0432.CCR-09-0695
PMid:19861460
64. Strojnik T, Rosland GV, Sakariassen PO, et al. Neural stem cell markers, nestin and musashi proteins, in the progress of human glioma: correlation of nestin with prognosis of parient survival. Surg Neurol. 2007; 68(2):133–144.
https://doi.org/10.1016/j.surneu.2006.10.050
PMid:17537489
65. Pallini R, Ricci-Vitiani L, Banna GL, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res. 2008; 14(24):8205–8212.
https://doi.org/10.1158/1078-0432.CCR-08-0644
PMid:19088037
66. Chinnaiyan P, Wang M, Rojiani AM, et al. The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the radiation therapy oncology group. Radiation Oncology. 2008; 3(1):32–40.
https://doi.org/10.1186/1748-717X-3-32
PMid:18817556 PMCid:PMC2563009
67. Burkhardt JK, Shin BJ, Boockvar JA. Neural Stem Cells and Glioma Stem-Like Cells Respond Differently to Chemotherapeutic Drugs: Selectivity at the Cellular Level. Neurosurgery. 2011; 68(6):21–22.
https://doi.org/10.1227/01.neu.0000398212.65736.e1
PMid:21778947
68. Gong X, Schwartz PH, Linskey ME, et al. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy. Neurology. 2011; 76(13):1126–1134.
https://doi.org/10.1212/WNL.0b013e318212a89f
PMid:21346220 PMCid:PMC3269770

Semenova VM, Lisyany NI, Rosumenko VD, Egorova DM, Staino LP. The biological properties of cancer stem cells in malignant gliomas in tissue culture: a review. Cell and Organ Transplantology. 2015; 3(2):163-168. doi: 10.22494/COT.V3I2.12

 

Creative Commons License
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.